Literature DB >> 32219546

Seroprevalence and factors associated with hepatitis B virus infection in blood donors in Ethiopia: a systematic review and meta-analysis.

Robera Olana Fite1, Wesam Kooti2, Gedion Asnake Azeze3, Bekele Tesfaye4, Shemsu Nuriye Hagisso5.   

Abstract

Hepatitis B virus (HBV) can be transmitted during blood donation. This study estimated the pooled prevalence of hepatitis B and associated risk factors in blood donors in Ethiopia. The study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. PubMed, African Journals Online (AJOL), the Excerpta Medica database (EMBASE), SCOPUS, Web of Science, Google Scholar, and JSTOR were accessed. Articles were searched from the Addis Ababa University research repository. The core search terms and phrases were "Hepatitis", "Hepatitis B", "Blood Donation", "Blood Donor", "Transfusion", "Transfusion Transmissible Infections", "Ethiopia", "Addis Ababa", "Adama", "Bahirdar", "Dire Dawa", "Gondar", "Mekelle", "Hawassa". The data were analyzed based on a DerSimonian-Laird random-effects model using STATA 14 and Review Manager version 5.3. I2 was used to quantify between-study heterogeneity. Leave-one-out sensitivity analysis was done. Twenty-seven articles with 308,188 samples were included in the meta-analysis. The studies used HBsAg to diagnose hepatitis B. The pooled prevalence of HBV infection among blood donors was 4.91% (95% CI: 4.21-5.60; I2 = 99%). Male sex (p < 0.001), replacement donors (p = 0.007), history of tooth extraction (p < 0.001), and sharp material sharing (p < 0.001) were associated with increased risk, while being a repetitive blood donor was associated with a decreased risk of being infected with HBV (p = 0.02).

Entities:  

Year:  2020        PMID: 32219546     DOI: 10.1007/s00705-020-04591-w

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  2 in total

1.  Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS).

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Mohammadreza Naghipour; Soheil Hassanipour; Sara Yeganeh; Masood Sepehrimanesh; Mohammad Fathalipour
Journal:  BMC Res Notes       Date:  2021-02-10

2.  The Safety, Immunogenicity, and Immunopersistence of Hepatitis A Vaccine in HBs-Ag-Positive Participants: A Retrospective Study.

Authors:  Xiaodan Wang; Jia Luo; Fubao Ma; Guodong Kang; Zhengrong Ding; Yue Pan; Yujiao Zhao; Junying Chen; Kai Feng; Lingmei Yan; Juan Zhang; Linhao Li; Qiangping Lan; Daiying Li; Xiaolei Yang; Guoliang Li; Jingsi Yang; Qiangming Sun
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.